77 results
POS AM
ABVC
ABVC BioPharma Inc
25 Apr 24
Prospectus update (post-effective amendment)
2:38pm
and expenses of marketing these medicines, which in turn could cause our revenues and net income to decline. In addition, the reputation and sales of our future … result in:
decreased demand for our product candidates or products that we may develop;
injury to our reputation and significant negative media
424B4
ABVC
ABVC BioPharma Inc
5 Apr 24
Prospectus supplement with pricing info
2:47pm
these medicines, which in turn could cause our revenues and net income to decline. In addition, the reputation and sales of our future medicines could … in:
decreased demand for our product candidates or products that we may develop;
injury to our reputation and significant negative media attention
DEFA14A
ABVC
ABVC BioPharma Inc
25 Mar 24
Additional proxy soliciting materials
4:30pm
to decline. In addition, the reputation and sales of our future medicines could be adversely affected due to the severe side effects discovered.
We may … ;
injury to our reputation and significant negative media attention;
withdrawal of clinical trial participants;
significant costs to defend resulting
8-K
EX-10.1
249m8mp68jr94m8u6
23 Jun 23
Departure of Directors or Certain Officers
4:01pm
424B4
09owlwa8tcq4q0cyq53
12 Jun 23
Prospectus supplement with pricing info
4:30pm
POS AM
jzk0fkygqo3ae7cbswgx
26 Apr 23
Prospectus update (post-effective amendment)
2:08pm
POS AM
25l kl1bik6u0ieb
26 Apr 23
Prospectus update (post-effective amendment)
1:29pm